Active Ingredient(s): Brivaracetam
FDA Approved: * February 18, 2016
Pharm Company: * UCB INC
Category: Anticonvulsant

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Briviact Overview

Brivaracetam, sold under the brand name Briviact and Brivazen among others, a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties.[2][3] It is marketed by the pharmaceutical company UCB.[4][5] In India it is co-promoted and distributed by Dr. Reddy's Laboratories.[not verified in body] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4....

Read more Briviact Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Briviact Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 50mg/ml
  • Solution: 10mg/ml, 50mg/5ml (10mg/ml)
  • Tablet: 100mg, 10mg, 25mg, 50mg, 75mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Briviact: (7 results)

Sorted by National Drug Code
  • 50474-370 Briviact 10 mg Oral Tablet, Film Coated by Ucb, Inc.
  • 50474-470 Briviact 25 mg Oral Tablet, Film Coated by Ucb, Inc.
  • 50474-570 Briviact 50 mg Oral Tablet, Film Coated by Ucb, Inc.
  • 50474-670 Briviact 75 mg Oral Tablet, Film Coated by Ucb, Inc.
  • 50474-770 Briviact 100 mg Oral Tablet, Film Coated by Ucb, Inc.
  • 50474-870 Briviact 10 mg/ml Oral Solution by Ucb, Inc.
  • 50474-970 Briviact 50 mg/5ml Intravenous Injection, Suspension by Ucb, Inc.

Other drugs which contain Brivaracetam or a similar ingredient: (1 result)